ERYTECH PHARMA's ticker is ERYP and the CUSIP is 29604W108. A total of 7 filers reported holding ERYTECH PHARMA in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| StoneX Group Inc. | 17,304 | $13 | 0.00% |
| Baader Bank Aktiengesellschaft | 24,000 | $14,716 | 0.00% |
| Vanguard Personalized Indexing Management, LLC | 24,271 | $18,689 | 0.00% |
| Citadel Advisors | 400 | $292 | 0.00% |
| Citadel Advisors | 16,606 | $12,122 | 0.00% |
| Asset Dedication, LLC | 4,000 | $3 | 0.00% |
| Ikarian Capital, LLC | 3,019 | $2,257 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 10,590 | $7,731 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 12,069 | $8,810 | 0.00% |